Lv2
150 积分 2021-12-21 加入
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2个月前
已完结
Pharmacological Treatment of Idiopathic Pulmonary Fibrosis (Update) and Progressive Pulmonary Fibroses: S2k Guideline of the German Respiratory Society
2个月前
已完结
《成人特发性肺纤维化（更新）和进展性肺纤维化：ATS/ERS/JRS/ALAT临床实践指南（2022版）》解读（二）
2个月前
已完结
HER-2变异晚期非小细胞肺癌诊疗专家共识（2025版）
2个月前
已完结
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk
3个月前
已完结
[Expert consensus on the clinical application of PI3K/AKT/mTOR inhibitors in the treatment of advanced breast cancer]
3个月前
已完结
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
4个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
4个月前
已完结
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
4个月前
已关闭
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
4个月前
已完结
皖公网安备34019202002308
